Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OCEA

Ocean Biomedical (OCEA) Stock Price, News & Analysis

About Ocean Biomedical Stock (NASDAQ:OCEA)

Advanced Chart

Key Stats

Today's Range
$0.0053
$0.0165
50-Day Range
N/A
52-Week Range
$0.01
$2.09
Volume
64.85 million shs
Average Volume
16.38 million shs
Market Capitalization
$341,726.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.

Ocean Biomedical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

OCEA MarketRank™: 

Ocean Biomedical scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Ocean Biomedical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ocean Biomedical is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ocean Biomedical is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    2.49% of the float of Ocean Biomedical has been sold short.
  • Short Interest Ratio / Days to Cover

    Ocean Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ocean Biomedical has recently increased by 1,206.29%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Ocean Biomedical does not currently pay a dividend.

  • Dividend Growth

    Ocean Biomedical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.49% of the float of Ocean Biomedical has been sold short.
  • Short Interest Ratio / Days to Cover

    Ocean Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ocean Biomedical has recently increased by 1,206.29%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Ocean Biomedical this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for OCEA on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Ocean Biomedical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ocean Biomedical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    73.50% of the stock of Ocean Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 24.55% of the stock of Ocean Biomedical is held by institutions.

  • Read more about Ocean Biomedical's insider trading history.
Receive OCEA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ocean Biomedical and its competitors with MarketBeat's FREE daily newsletter.

OCEA Stock News Headlines

Ocean Biomedical Inc.
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Ocean Biomedical granted notice of grant on patent right by CNIPA
Four board members to exit troubled RI biotech
See More Headlines

OCEA Stock Analysis - Frequently Asked Questions

Ocean Biomedical, Inc. (NASDAQ:OCEA) announced its quarterly earnings data on Tuesday, April, 8th. The company reported $0.02 EPS for the quarter.

Ocean Biomedical (OCEA) raised $22 million in an initial public offering on the week of April 18th 2022. The company issued 2,000,000 shares at a price of $10.00-$12.00 per share. Roth Capital Partners and JonesTrading served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ocean Biomedical investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Alphabet (GOOG), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM) and Home Depot (HD).

Company Calendar

Last Earnings
4/08/2025
Today
4/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OCEA
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-114,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($2.62) per share
Price / Book
0.00

Miscellaneous

Free Float
9,240,000
Market Cap
$341,726.00
Optionable
Optionable
Beta
1.31
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:OCEA) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners